Never miss an update from Yeda
Create your free account to connect with Yeda and thousands of other innovative organizations and professionals worldwide
Childhood obesity is a global health crisis, which holds extended complex health and psychological problems.
Although an early diagnosis of children at risk for obesity could allow intervention and prevention, healthcare professionals have little guidance to identify individuals at risk. The current technology provides a method to identify individuals at high risk of developing childhood obesity before two years old, allowing early intervention and possible prevention of future obesity.
Background and Unmet Need
Over the past years, an alarming increase in childhood obesity has become a public health crisis, rising complex health issues, and psychological problems. It is associated with a greater risk for premature mortality and earlier onset of chronic disorders such as hypertension, dyslipidemia, ischemic heart disease, and type 2 diabetes.
Identifying young children at risk could provide a critical time window for intervention by promoting healthy eating habits and encouraging physical activity. However, there is currently an underestimation of obesity by parents and physicians and there is currently little guidance for health care professionals to identify infants at risk. Therefore, there is a great need for a system/method for early diagnosis of children who are at risk of becoming obese.
The Solution
Prof. Eran Segal and his team have developed a method for predicting childhood obesity based on parameters from electronic health records.1
Technology Essence
Prof. Segal and his team analyzed children’s electronic health records (EHR) from Israel’s largest healthcare provider. They analyzed retrospective data of almost 418000 children who were obese/not obese at 13-14. Based on this data, they found that the largest annual increase in body mass index (BMI) was observed at 2-4 years of age. Therefore, they constructed a model that identifies children before the age of 2 years who will be at high risk for obesity at age 5-6 years old. The computational model uses data from EHR (or from a questionnaire) containing parameters that characterize an infant or toddler subject, utilizing a machine learning procedure trained to predict likelihoods for childhood obesity.
Applications and Advantages
Development Status
The group of Prof. Eran Segal fully developed the computational method for predicting childhood obesity and validated it temporally and geographically, accurately predicting obesity at 5-6 years old (area under the receiver operating characteristic curve of 0.803 – Figure 1).
Figure 1 - Evaluation of obesity prediction model: ROC curve of our model (blue) and a baseline model based on the last
available Weight-for-length routine checkup measurement (red diamond). The blue dots and percentages represent different decision probability thresholds.
References
Rossman H, Shilo S, Barbash-Hazan S, et al. Prediction of Childhood Obesity from Nationwide Health Records. J Pediatr. 2021;233:132-140.e1. doi:10.1016/j.jpeds.2021.02.010 [1]
Yeda ("Knowledge" in Hebrew) Research and Development Company Ltd. is the commercial arm of the Weizmann Institute of Science (WIS) and is the second company of its kind established in the world.
WIS is one of the world’s leading multidisciplinary basic research institutions in the natural and exact sciences. It is located in Rehovot, Israel, just south of Tel Aviv. It was initially established as the Daniel Sieff Institute in 1934, by Israel and Rebecca Sieff of London in memory of their son Daniel. In 1949, it was renamed for Dr. Chaim Weizmann, the first President of the State of Israel and Founder of the Institute.
Yeda initiates and promotes the transfer to the global marketplace of research findings and innovative technologies developed by WIS scientists. Yeda holds an exclusive agreement with WIS to market and commercialize its intellectual property and generate income to support further research and education.
Since 1959 Yeda has generated the highest income per researcher compared to any other TTO worldwide. Weizmann has generated a number of groundbreaking therapies, such as Copaxone, Rebif, Tookad, Erbitux, Vectibix, Protrazza, Humira, and recently the CAR-T cancer therapy Yescarta.
Yeda performs the following activities:
◣ Identifies and assesses research projects with commercial potential.
◣ Protects the intellectual property of WIS and its scientists.
◣ Licenses WIS' inventions and technologies to industry.
◣ Establishes new Startup companies based in WIS Intellectual Property
◣ Channels funding from industry to research projects.
Our portfolio covers a broad spectrum of the natural sciences, including:
◣ Agriculture and Plant Genetics, including Bio-fuels
◣ Chemistry and Nanotechnology
◣ Environmental Sciences and Solar Energy
◣ Mathematics and Computer Science
◣ Medical Devices
◣ Pharmaceuticals and Diagnostics
◣ Physics and Electro-Optics
◣ Research Tools
Create your free account to connect with Yeda and thousands of other innovative organizations and professionals worldwide
Send a request for information
to Yeda
Technology Offers on Innoget are directly posted
and managed by its members as well as evaluation of requests for information. Innoget is the trusted open innovation and science network aimed at directly connect industry needs with professionals online.
Need help requesting additional information or have questions regarding this Technology Offer?
Contact Innoget support